We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $3.05B
1-Year Est. Return 42.09%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+42.09%
3 Year Est. Return
+130.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
-$51.8M
Cap. Flow
+$18.3M
Cap. Flow %
6.2%
Top 10 Hldgs %
42.74%
Holding
50
New
7
Increased
13
Reduced
21
Closed
5

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.57%
2 Miscellaneous 14.1%
3 Technology 13.03%
4 Financials 9.83%
5 Healthcare 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLT icon
1
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.3B
$30.1M 10.2%
+228,000
New +$31.4M
OVV icon
2
Ovintiv
OVV
$16.6B
$14.4M 4.88%
266,200
-4,375
-2% -$189K
AMZN icon
3
Amazon
AMZN
$2.69T
$11.2M 3.79%
68,700
+44,700
+186% +$6.91M
BABA icon
4
Alibaba
BABA
$273B
$11.2M 3.79%
102,800
+26,600
+35% +$3.06M
NCLH icon
5
Norwegian Cruise Line
NCLH
$6.71B
$10.7M 3.64%
491,100
-17,700
-3% -$362K
DXC icon
6
DXC Technology
DXC
$1.7B
$9.84M 3.33%
301,600
-22,100
-7% -$731K
DAL icon
7
Delta Air Lines
DAL
$55.9B
$9.81M 3.32%
248,000
+5,000
+2% +$195K
COIN icon
8
CALL
Coinbase
COIN
$51.5B
$9.78M 3.31%
51,500
-1,500
-3% -$293K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.21T
$9.57M 3.24%
68,800
-4,900
-7% -$666K
CLF icon
10
Cleveland-Cliffs
CLF
$6.95B
$9.52M 3.23%
+295,700
New +$6.74M
MAT icon
11
Mattel
MAT
$3.8B
$9.48M 3.21%
427,000
+23,300
+6% +$533K
TEVA icon
12
Teva Pharmaceutical Industries Limited
TEVA
$45.7B
$9.4M 3.18%
1,000,850
+250,950
+33% +$2.09M
TVTY
13
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$8.09M 2.74%
251,600
-92,800
-27% -$2.51M
META icon
14
Meta Platforms (Facebook)
META
$1.91T
$7.77M 2.63%
34,950
+3,550
+11% +$887K
OMF icon
15
OneMain Financial
OMF
$6.6B
$7.48M 2.53%
157,700
+52,300
+50% +$2.61M
GM icon
16
General Motors
GM
$72.5B
$7.1M 2.41%
162,400
+5,000
+3% +$250K
FISV
17
Fiserv Inc
FISV
$24.7B
$7.02M 2.38%
69,200
+3,600
+5% +$364K
ADT icon
18
ADT
ADT
$4.68B
$6.86M 2.32%
904,000
-70,800
-7% -$539K
ET icon
19
Energy Transfer Partners
ET
$69.5B
$6.82M 2.31%
609,400
-87,600
-13% -$869K
SPLK
20
DELISTED
Splunk Inc
SPLK
$6.76M 2.29%
45,500
-12,200
-21% -$1.49M
FTCH
21
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$6.6M 2.24%
436,800
+178,400
+69% +$3.45M
BHC icon
22
Bausch Health
BHC
$2.13B
$6.2M 2.1%
271,300
-19,000
-7% -$464K
HLF icon
23
Herbalife
HLF
$1.32B
$5.9M 2%
194,300
+13,500
+7% +$528K
TUP
24
DELISTED
Tupperware Brands Corporation
TUP
$5.84M 1.98%
300,300
+17,200
+6% +$293K
AVID
25
DELISTED
Avid Technology Inc
AVID
$5.64M 1.91%
161,700
-65,600
-29% -$2.04M

Similar funds

Patient Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Patient Capital Management held 50 positions worth $295M, down 15% from $347M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Patient Capital Management deployed $18.3M of net new capital in Q1 2022, opening 7 new positions and adding to 13 existing holdings. Its largest new stake was Cleveland-Cliffs: 295,700 shares worth $9.52M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 18% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Diamondback Energy, an estimated $5.23M trimmed.

  • Patient Capital Management's largest Q1 2022 buy was Cleveland-Cliffs: 295,700 shares worth $9.52M.
  • Patient Capital Management added most to Amazon in Q1 2022, an estimated $6.91M increase.
  • Patient Capital Management's biggest Q1 2022 reduction was Diamondback Energy, cutting an estimated $5.23M.
  • Patient Capital Management fully exited The RealReal in Q1 2022, selling an estimated $2.01M.
  • Patient Capital Management's ten largest holdings make up 43% of its $295M portfolio in Q1 2022.
  • Patient Capital Management opened 7 new positions and closed 5 in Q1 2022.
  • Patient Capital Management's portfolio value fell 15% quarter-over-quarter to $295M.

Based on Patient Capital Management's 13F filing for Q1 2022, filed 16 May 2022.